
PDGFR
PDGFR (platelet-derived growth factor receptor) inhibitors are compounds that block the signaling of PDGFR, a receptor involved in cell growth, proliferation, and angiogenesis. PDGFR plays a significant role in the development of the blood vessels that supply tumors. Inhibiting PDGFR can therefore prevent angiogenesis, making these inhibitors valuable in cancer therapy. At CymitQuimica, we provide a selection of high-quality PDGFR inhibitors to support your research in oncology, vascular biology, and angiogenesis.
Found 130 products for "PDGFR".
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
Tyrphostin RG 13022
CAS:Formula:C16H14N2O2Purity:>98.0%(GC)Color and Shape:White to Yellow to Green powder to crystalMolecular weight:266.30Methyl 1-Acetyl-3-(ethoxyphenylmethylene)-2,3-dihydro-2-oxo-1H-indole-6-carboxylate
CAS:Formula:C21H19NO5Purity:>95.0%(HPLC)(qNMR)Color and Shape:White to Light yellow to Light orange powder to crystalMolecular weight:365.39Nintedanib
CAS:Formula:C31H33N5O4Purity:>95.0%(HPLC)(T)Color and Shape:White to Yellow to Yellow green powder to crystalMolecular weight:539.64AG-1296
CAS:Formula:C16H14N2O2Purity:>98.0%(GC)Color and Shape:White to Orange to Green powder to crystalMolecular weight:266.30Regorafenib
CAS:Formula:C21H15ClF4N4O3Purity:>98.0%(HPLC)Color and Shape:White to Light yellow to Light orange powder to crystalMolecular weight:482.82Sorafenib Tosylate
CAS:Formula:C21H16ClF3N4O3·C7H8O3SPurity:>98.0%(HPLC)(T)Color and Shape:White to Light yellow powder to crystalMolecular weight:637.03TCS 359
CAS:Formula:C18H20N2O4SPurity:>98.0%(HPLC)Color and Shape:Light yellow to Brown powder to crystalMolecular weight:360.43Imatinib Mesylate
CAS:Formula:C29H31N7O·CH4O3SPurity:>98.0%(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:589.72Dasatinib
CAS:Formula:C22H26ClN7O2SPurity:>95.0%(HPLC)(T)Color and Shape:White to Light yellow powder to crystalMolecular weight:488.01Linifanib
CAS:Formula:C21H18FN5OPurity:>95.0%(HPLC)(qNMR)Color and Shape:White to Light yellow powder to crystalMolecular weight:375.41Imatinib
CAS:Formula:C29H31N7OPurity:>98.0%(HPLC)Color and Shape:White to Light yellow to Light orange powder to crystalMolecular weight:493.62Trapidil
CAS:Formula:C10H15N5Purity:>98.0%(HPLC)(qNMR)Color and Shape:White to Light yellow powder to crystalMolecular weight:205.27GW 2580
CAS:Formula:C20H22N4O3Purity:>98.0%(HPLC)Color and Shape:White to Light yellow to Light orange powder to crystalMolecular weight:366.42Tyrphostin A9
CAS:Formula:C18H22N2OPurity:>98.0%(GC)Color and Shape:Light orange to Yellow to Green powder to crystalMolecular weight:282.39Olaratumab
CAS:Olaratumab(IMC-3G3) is a human monoclonal IgG1 antibody against platelet-derived growth factor receptor alpha (PDGFRα), which has antitumor effects and can bePurity:SDS-PAGE:95% SEC-HPLC:98.70%Color and Shape:Transparent LiquidMolecular weight:147.12 kDa (Predicted)Trapidil
CAS:Trapidil (Avantrin) is a coronary vasodilator agent.Formula:C10H15N5Purity:99.42%Color and Shape:White SolidMolecular weight:205.2596AG 1295
CAS:AG 1295 is a selective PDGFR tyrosine-kinase inhibitor; it blocks PDGFR autophosphorylation without affecting EGF receptor.Formula:C16H14N2Purity:99.93%Color and Shape:SolidMolecular weight:234.2958Regorafénib N-oxyde (M2)
CAS:Regorafénib N-oxyde M2 is an active metabolite of Regorafenib.Formula:C21H15ClF4N4O4Purity:98.03% - 98.26%Color and Shape:White SolidMolecular weight:498.815JNJ-10198409
CAS:JNJ-10198409: selective ATP competitive PDGF-RTK inhibitor; IC50: PDGFR-β 4.2 nM, PDGFR-α 45 nM; antiangiogenic & antiproliferative.Formula:C18H16FN3O2Purity:99.15%Color and Shape:Yellow SolidMolecular weight:325.3369


